Table 2.
Concentrations of Klotho, SCr/Kl, SCr and cys-C after operation
| Baseline | 0 h | 4 h | 1 d | 2 d | 3 d | ||
|---|---|---|---|---|---|---|---|
| Klotho | AKI | 121.64±19.87 | 101.97±16.93*,# | 102.77±14.44 | 111.85±11.78 | 116.58±12.73 | 120.50±13.17 |
| N-AKI | 122.76±20.18 | 124.40±20.66 | 118.10±18.74 | 120.43±17.55 | 126.29±17.78 | 128.67±18.84 | |
| SCr | AKI | 73.37±11.66 | 99.05±16.51*,# | 125.37±21.88★ | 128.37±43.56 | 131.58±62.57 | 120.42±63.53 |
| N-AKI | 73.19±16.67 | 74.56±12.43 | 86.13±20.73 | 71.94±20.58 | 71.88±22.00 | 71.19±.23.30 | |
| SCr/Kl | AKI | 0.621±0.151 | 0.997±0.238*,# | 1.256±0.328 | 1.166±0.427 | 1.148±0.550 | 1.018±0.557 |
| N-AKI | 0.606±0.174 | 0.600±0.169 | 0.749±0.246 | 0.606±0.212 | 0.583±0.209 | 0.569±0.206 | |
| Cys-C | AKI | 1.073±0.204 | 1.120±0.257*,# | 1.394±0.364 | 1.652±0.293 | 1.896±0.414 | 2.006±0.440 |
| N-AKI | 0.997±0.164 | 0.935±0.180 | 0.950±0.222 | 1.094±0.254 | 1.094±0.254 | 1.099±0.332 |
*
P<0.05, Biomarkers compared with the non-AKI group;
#
P<0.05, Biomarkers compared with baseline;
★
Reaching the AKIN criteria.